You just read:

Trovagene Announces Peer-Reviewed Publication of First-in-Human Phase 1 Trial Results with PCM-075, its Polo-like Kinase 1 (PLK1) Inhibitor

News provided by

Trovagene, Inc.

Jul 25, 2017, 08:00 ET